Integrative Care Solutions for Sustainable Results from Obesity

Find effective strategies through integrative care for obesity, combining medical and lifestyle approaches for weight loss.

Abstract

In this educational post, I present a clear, patient-centered roadmap for addressing obesity, a complex, multifaceted disease influenced by genetics, metabolic function, hormonal imbalances, and mental health. Drawing from my years of practice in integrative and functional medicine, I synthesize the latest evidence-based research to explore the intricate connections between weight and key aspects of health, including reproductive wellness (with an emphasis on polycystic ovary syndrome), sleep, and psychiatric considerations. We will delve into how to identify and treat comorbid conditions like insulin resistance, prediabetes, and nutrient deficiencies, and explore the generational impact of parental health on offspring. I will share practical clinical insights and real-world case studies from my work in El Paso, Texas, where we integrate chiropractic care, functional medicine, and medical oversight within a multidisciplinary framework. I explain how insulin resistance underpins many chronic conditions, why dietary patterns (especially lower-carbohydrate strategies), physical activity dosing, and medication selection matter, and how integrative chiropractic care supports autonomic balance, musculoskeletal function, and pain reduction—thereby improving adherence to lifestyle changes. I also detail how our team, including our Medical Director, Dr. Maria Guadalupe Cardenas, MD, collaborates to deliver comprehensive, holistic care. This article is designed to be easy to read, fully elaborated, and deeply grounded in physiology and clinical reasoning, guiding readers through a modern, evidence-based approach to lasting wellness.

Our Integrated Care Philosophy: A Multidisciplinary Team

At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, we have cultivated a unique, multidisciplinary environment designed to provide the most comprehensive care possible. I am Dr. Alex Jimenez, and my credentials as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN, FNP-BC), and certifications in functional medicine (CFMP, IFMCP, ATN, CCST) allow me to view health through a wide-angle lens, focusing on the body’s structural integrity, neurological function, and the biochemical pathways that govern our health.

The cornerstone of our clinic is our collaboration with Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933) and brings over 40 years of invaluable experience as an internist. She serves as our Medical Director and Collaborative Physician, providing essential medical oversight, managing prescription medications, and ensuring our protocols reflect the highest standards of internal medicine. This multidisciplinary setup, common in integrative and injury care clinics, allows us to seamlessly blend the principles of chiropractic care with the diagnostic and pharmacological expertise of internal medicine.

Our clinical ecosystem integrates:

• Internal Medicine Oversight: Led by Dr. Cardenas for comprehensive diagnostics, comorbidity management, and medication optimization.
• Chiropractic Care: A structural integrative approach focused on spinal health, biomechanics, and achieving autonomic and neuro-musculoskeletal balance.
• Functional Medicine: Investigating the root causes of chronic illness through analysis of nutrition, lifestyle, gut health, and metabolic function.
• Personal Injury Care and Rehabilitation: Addressing musculoskeletal injuries, restoring function, and modulating pain to support recovery.
• Nutritional and Behavioral Health Support: Empowering patients with the tools for sustainable health, including stress management and sleep optimization.
• Collaboration with Specialty Partners: We work with OB/GYN, endocrinology, psychiatry, and sleep medicine specialists as needed to provide truly holistic care.

This model is particularly effective for complex conditions in which mental, physical, and metabolic health intersect, enabling us to develop personalized, highly effective treatment protocols for our patients here in El Paso, Texas.

How Integrative Chiropractic Care Fits Into Obesity Treatment

Chiropractic care is not a weight-loss treatment per se; rather, it is a crucial supportive therapy that optimizes the musculoskeletal and autonomic nervous systems. By doing so, we can improve movement, reduce pain, enhance sleep, and support adherence to the nutrition and physical activity plans that are the key drivers of metabolic change.

We use chiropractic methods that:

• Improve spinal biomechanics and reduce nociceptive (pain signal) input. This helps lower sympathetic overdrive (“fight-or-flight” response) and support autonomic balance. Enhanced vagal tone, a measure of parasympathetic (“rest-and-digest”) activity, correlates with improved insulin sensitivity and lower inflammation (Thayer & Lane, 2009; Kemp et al., 2017).
• Reduce pain and functional limitations. This is often the biggest barrier to exercise. By alleviating joint and back pain, we enable patients to achieve the regular low- to moderate-intensity physical activity that improves glucose disposal and insulin signaling in skeletal muscle (Hawley & Lessard, 2008).
• Enhance breathing mechanics, thoracic mobility, and rib-cage function. Improving sleep posture and ventilation can reduce sleep fragmentation and indirectly support the regulation of appetite-regulating hormones such as leptin and ghrelin (Taheri et al., 2004).
• Integrate soft tissue therapies and neuromuscular re-education. These techniques help stabilize joints and correct faulty movement patterns, which reduces injury risk and facilitates sustained, enjoyable activity.

With Dr. Cardenas’ oversight, our chiropractic strategies are delivered in coordination with medical assessments, ensuring they are appropriate and safe, especially when conditions like pregnancy, hypertension, or diabetes are present.

The Intricate Dance of Mind, Sleep, and Weight

From my clinical experience, I’ve observed that the journey of chronic illness often begins with stress. The effects of chronic stress are not just “in your head”; they manifest physically, starting a powerful inflammatory cascade. This low-grade, simmering inflammation disrupts the body’s delicate balance, leading to a host of symptoms:

• Sleep Disturbances and Chronic Fatigue
• Altered Eating Habits, including cravings for high-sugar, high-fat “comfort” foods
• Insulin Resistance and a Slowed Metabolism
• Cognitive Decline, often described as “brain fog”
• Hormonal Imbalance due to elevated stress hormones like cortisol

When this inflammation is compounded by overweight or obesity, it creates a vicious cycle. The excess adipose (fat) tissue is an active endocrine organ that produces its own inflammatory signals, further fueling the fire. Add sleep disturbances to the mix, and our basal metabolic rate—the energy we burn at rest—slows even further.

Psychiatric Considerations: Mood, Anxiety, and Eating Disorders

Because the mind-body connection is so strong, we screen for several conditions that can profoundly affect a patient’s weight health journey, including anxiety, depression, PTSD, bipolar disorder, and ADHD. Adults with obesity face elevated rates of these conditions, and in women with PCOS, these risks are heightened due to hormonal, metabolic, and psychosocial factors.

Mechanisms:

• Inflammation (elevated CRP, IL-6) affects neurotransmission, while insulin resistance and fluctuating sex steroid levels affect the serotonergic and dopaminergic systems.
• Sleep disruption worsens mood and appetite regulation.
• Chronic pain increases catastrophizing and avoidance behaviors.

Clinical Approach:

• Screening: We use validated tools like the PHQ-9 (depression), GAD-7 (anxiety), and SCOFF (eating disorders) to guide our evaluation and referrals to behavioral health specialists.
• Integrated Plan: We create a plan that addresses these issues in parallel. Nutrition plans emphasize satiety and address emotional eating. Low-barrier physical activity improves mood via endocannabinoid and BDNF. Chiropractic care reduces the depressive load of chronic pain and improves self-efficacy.
• Medical Management: Under Dr. Cardenas’s direction, we carefully select medications that minimize weight gain (e.g., bupropion for depression) and regularly monitor metabolic health. It is often beneficial to treat obesity first, as the resulting improvements in energy and self-esteem can provide the momentum needed to address deeper psychological issues.

The Overlap Between Eating Disorders and Weight Health

It is critical to screen for common eating disorders such as anorexia nervosa, bulimia nervosa, binge eating disorder (BED), and avoidant/restrictive food intake disorder (ARFID). These are complex mental health conditions requiring specialized intervention. Startlingly, eating disorders have the second-highest mortality rate of all psychiatric illnesses, with one person dying every 52 minutes as a direct result (Arcelus et al., 2011; Eating Disorders Coalition, 2016). It is a misconception that people with these disorders are always underweight; in fact, less than 6% are medically underweight (Walsh et al., 2022).

We must also recognize disordered eating, which describes problematic eating behaviors that don’t meet full diagnostic criteria but are far more common in individuals with obesity. Because disordered eating often drives weight issues, we can consider anti-obesity medications targeted at specific cues:

• Constant thoughts of food: The bupropion-naltrexone combination may be helpful.
• Inability to control hunger: Phentermine or the phentermine-topiramate combination could be considered.
• Cravings or inability to stop eating: GLP-1 agonists like semaglutide or tirzepatide can be incredibly effective.

Sleep: The Unsung Hero of Metabolic Health

Sleep is not a luxury; it is a biological necessity. The recommended 7-9 hours of quality sleep per night is crucial for metabolic health, as it regulates appetite hormones (ghrelin and leptin), suppresses fat preservation, and supports healthy circadian rhythms.

Obstructive Sleep Apnea (OSA) is a condition where the airway is temporarily blocked during sleep, preventing restorative rest. Excess body weight is a major risk factor, and the condition itself perpetuates weight gain by disrupting hunger hormones. If untreated, OSA leads to severe daytime fatigue, weight gain, and increased cardiovascular risk. We screen for OSA using the STOP-BANG questionnaire and Epworth Sleepiness Scale. Treatment with CPAP, paired with weight loss, can dramatically improve glycemic control and daytime function. Excitingly, tirzepatide was recently shown to significantly reduce apnea events in patients with obesity, highlighting the powerful link between metabolic health and sleep (Suratt Trial Investigators et al., 2024).

Reproductive Health in Obesity: Understanding PCOS and Preconception Wellness

Adults aged 18–40 often navigate pregnancy or plan for it. My work is heavily focused on preconception health because a parent’s health status creates a lasting imprint on their child. This is the concept of epigenetics—how our behaviors and environment can cause changes that affect the way our genes work. Both maternal and paternal adiposity can epigenetically program their offspring for a higher risk of obesity, cardiovascular disease, and type 2 diabetes, creating a pattern of generational obesity. By improving a person’s metabolic function before they conceive, we can make a substantial, positive impact on the health of generations to come.

Polycystic Ovary Syndrome (PCOS) and Metabolic Risk

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, affecting approximately 10% of this population (Azziz et al., 2016). I frame PCOS as a chronic, lifespan condition with cardiometabolic implications. It frequently coexists with obesity and insulin resistance, and this triad shares a common pathophysiology.

Physiology: Why Insulin Resistance Drives PCOS

• Insulin resistance leads to elevated circulating insulin (hyperinsulinemia). This excess insulin binds to ovarian theca cells and amplifies androgen (male hormone) production (Dunaif, 1997; Diamanti-Kandarakis & Dunaif, 2012).
• Elevated androgens impair follicular maturation, leading to oligo-ovulation or anovulation (infrequent or absent ovulation) and menstrual irregularity.
• Hyperinsulinemia also raises LH pulsatility and decreases sex hormone-binding globulin (SHBG), which further increases free testosterone.
• Adipose tissue inflammation worsens hepatic insulin resistance and contributes to metabolic dysfunction-associated steatotic liver disease (MASLD) (Tilg et al., 2017).
• Long-term risks include gestational diabetes, hypertension, preeclampsia, type 2 diabetes, dyslipidemia, OSA, and higher rates of depression, anxiety, and eating disorders (Legro et al., 2013; Teede et al., 2023).

We diagnose PCOS using the Rotterdam 2003 criteria, which require two of the following: hyperandrogenism, ovulatory dysfunction, or polycystic ovarian morphology on ultrasound (Rotterdam ESHRE/ASRM, 2004).

Treatment Strategy: A Multi-Pronged Approach

Our strategy is to treat the underlying obesity and insulin resistance first. A modest weight reduction of 5–7% can restore menstrual cyclicity and spontaneous ovulation (Moran et al., 2011).

• Nutrition: Since insulin resistance reflects carbohydrate intolerance, we use evidence-informed lower-carbohydrate patterns that prioritize protein-first meals, non-starchy vegetables, and minimal ultra-processed foods. This lowers post-meal glucose and insulin, reduces fat storage (lipogenesis), and improves satiety (Ludwig et al., 2018).
• Physical Activity: We “dose” movement smartly. Short sessions (10–15 minutes), 2–3 times daily, can be more insulin-sensitizing than a single longer session due to repeated AMPK activation and improved GLUT4 translocation in skeletal muscle (Hawley & Lessard, 2008). We also add resistance training 1–2 times per week to increase lean mass and muscle glucose uptake.
• Pharmacotherapy: Under Dr. Cardenas’s supervision, we may use:

• • Metformin: To improve peripheral insulin sensitivity and favorably modulate ovarian hormone production (Nestler, 1998). We start with the extended-release form to minimize GI side effects.
  • GLP-1 Receptor Agonists: These medications effectively reduce adiposity and improve glycemic control, thereby enhancing ovulatory function (Wilding et al., 2021). It is crucial to note that these must be discontinued before attempting pregnancy, typically with a two-month washout period.
  • Spironolactone: For acne and hirsutism, with careful monitoring and contraception due to teratogenic potential.
  • Combined Oral Contraceptives: For cycle regulation and endometrial protection.

Obesity, Pregnancy, and Breastfeeding

In my practice, I frequently counsel women on the importance of metabolic health before, during, and after pregnancy. Obesity magnifies the natural insulin resistance of pregnancy, raising risks of gestational diabetes, hypertension, and preeclampsia (ACOG, 2021; Catalano & Shankar, 2017). We provide stigma-free care and coordinate with OB/GYNs to optimize nutrition and activity. Chiropractic techniques are modified to be pregnancy-safe, focusing on pelvic alignment and gentle soft-tissue work to reduce pain.

Postpartum, breastfeeding offers profound benefits for both mother and baby, including reduced lifetime risk of cancer, type 2 diabetes, and cardiovascular disease for the mother, and enhanced immunity and lower obesity risk for the child. However, women with obesity face barriers like delayed lactation and positioning difficulties. We proactively educate and connect mothers with lactation specialists to support them on this journey. A crucial point I always make is that a breastfeeding mother must eat enough to maintain an adequate milk supply; this is not the time for restrictive dieting.

Case Studies in Transformation: A Modern Approach in Action

Let’s put these concepts together through real-world case studies that illustrate our integrative, stepwise approach.

Case Study 1: Alex’s Journey with PCOS and Insulin Resistance

“Alex,” a 20-year-old college student, presented with a complex web of interrelated conditions: PCOS, insulin resistance, prediabetes, vitamin D deficiency, and a history of binge eating disorder, depression, and anxiety.

Our Phased and Collaborative Approach:

1. Foundational Treatment: We started Alex on metformin to improve insulin sensitivity and vitamin D to correct her deficiency.
2. Inter-Provider Collaboration: I spoke with her psychiatrist about her medications. Paroxetine, which can contribute to weight gain, was switched to sertraline, an option with a more favorable weight profile. This collaboration is essential.
3. Lifestyle Integration: We encouraged ten minutes of enjoyable activity daily to build a consistent habit. We focused on a low-carbohydrate, high-protein diet to manage insulin resistance and promote satiety.
4. Targeted Medication: Only after addressing these foundational issues did we introduce semaglutide, an anti-obesity medication, to further support her weight loss.
5. Chiropractic Support: Throughout her journey, integrative chiropractic care helped alleviate the joint and back pain that can accompany obesity, making it easier for her to stay active.

Remarkable Health Improvements:

Within three months, Alex had lost 10% of her body weight, and her lab parameters for insulin, blood sugar, and cholesterol had shown marked improvement. At six months, she achieved a 15% reduction in total body weight, and her lab values moved from dysfunctional ranges into the healthy, normal range—the ultimate goal of functional medicine.

Case Study 2: Natasha’s Journey to a Healthy Pregnancy

“Natasha,” a 33-year-old software engineer, wanted a second child but was determined to improve her health first. Her first pregnancy was complicated by preeclampsia, leading to an emergency C-section. Her clinical picture was concerning: class III obesity (BMI 40.9), prediabetes (A1C 6.1%), severe hyperinsulinemia, hypertension, and dyslipidemia.

The Stepwise Treatment Plan:

Our goal was to address these issues over one to two years before she attempted pregnancy.

1. Nutrition & Activity: We implemented a reduced-carbohydrate eating plan focused on protein and fiber, paired with a gradual increase in physical activity, starting with 10-minute walks.
2. Medication: We started metformin ER to combat her severe insulin resistance. Once she tolerated it, we added tirzepatide, a dual GIP/GLP-1 agonist, to drive effective weight reduction.

A Remarkable Transformation:

After two years, Natasha’s BMI had dropped from 40.9 to 28.8, and her A1C, fasting insulin, blood pressure, and lipids had all normalized. We then discontinued the tirzepatide, advised a two-month washout period, and she successfully conceived. She continued her healthy lifestyle and metformin throughout an uneventful pregnancy. Most beautifully, she successfully breastfed.

Case Study 3: Devon’s Marathon to a Healthier Life

“Devon,” a 40-year-old shift supervisor, presented with class III obesity, prediabetes, hypertension, and hyperlipidemia. His primary struggles were significant cravings and persistent hunger.

A Comprehensive Long-Term Plan:

1. Medical Management: We started him on atorvastatin for cholesterol, metformin for insulin resistance, and vitamin D.
2. Targeting Hunger: His hunger persisted even on semaglutide, so we later added phentermine. Due to an insurance change, we eventually transitioned him to tirzepatide and also incorporated topiramate.
3. Lifestyle Focus: We worked on meal planning to replace his one-large-meal-a-day pattern with two balanced meals, emphasizing protein and intentional exercise.
4. Chiropractic and Referrals: Chiropractic care supported his ability to engage in weight training and other activities. I also referred him to a cardiologist for an EKG before starting a stimulant and began an early, informative conversation about bariatric surgery as a potential future option.

Long-Term Success:

Devon’s journey shows that obesity is a chronic disease requiring ongoing management. Over several years, he has lost nearly 65 pounds and has maintained a 20% reduction in total body weight. All his lab parameters have normalized, demonstrating the power of a persistent, multi-therapy approach.

Beyond Adjustments: Chiropractic and Integrative Healthcare- Video

Clinical Observations and Final Thoughts

From my clinical experience, shared on platforms like HealthCoach Clinic and LinkedIn, I’ve seen several key patterns emerge:

• Patient adherence improves markedly when pain is controlled and movement feels safe; this is where chiropractic integration is pivotal.
• In PCOS, small but consistent improvements in sleep and movement correlate with earlier restoration of ovulatory cycles when these improvements are combined with nutrition and metformin.
• Structured morning movement (10–15 minutes) enhances glycemic patterns and reduces late-day cravings.
• Breathing mechanics training decreases perceived exertion during walking, enabling more frequent activity.

The stories of Alex, Natasha, and Devon demonstrate that there is no one-size-fits-all solution for obesity. Adults living with this chronic disease benefit from a coherent, compassionate, and integrated plan. By addressing the deep physiological drivers like insulin resistance, optimizing sleep, tackling psychiatric comorbidities, and seamlessly blending chiropractic care with internal medicine and functional strategies, we create a sustainable path forward. Our multidisciplinary structure, with Dr. Maria Guadalupe Cardenas, MD, as Medical Director, ensures medical rigor and safety, while our chiropractic and functional frameworks provide the personalized foundation for success. This is modern obesity care—evidence-based, integrative, and patient-centered.

References

• American College of Obstetricians and Gynecologists. (2021). Obesity in pregnancy. ACOG Practice Bulletin, No. 230.
• Arcelus, J., Mitchell, A. J., Wales, J., & Nielsen, S. (2011). Mortality rates in patients with anorexia nervosa and other eating disorders: A meta-analysis of 36 studies. Archives of General Psychiatry, 68(7), 724–731.
• Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., … & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2, 16057.
• Butte, N. F., & King, J. C. (2005). Energy requirements during pregnancy and lactation. Public Health Nutrition, 8(7A), 1010–1027.
• Catalano, P. M., & Shankar, K. (2017). Obesity and pregnancy: mechanisms of short-term and long-term adverse consequences for mother and child. BMJ, 356, j1.
• Diamanti-Kandarakis, E., & Dunaif, A. (2012). Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews, 33(6), 981–1030.
• Dunaif, A. (1997). Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews, 18(6), 774–800.
• Eating Disorders Coalition. (2016). Facts about eating disorders: What the research shows.
• Hawley, J. A., & Lessard, S. J. (2008). Exercise training-induced improvements in insulin action. Acta Physiologica, 192(1), 127–135.
• Herring, S. J., Oken, E., Rifas-Shiman, S. L., Rich-Edwards, J. W., & Gillman, M. W. (2010). Weight gain in pregnancy and risk of maternal hyperglycemia. American Journal of Obstetrics and Gynecology, 202(2), 159.e1-159.e7.
• Kemp, A. H., Koenig, J., & Thayer, J. F. (2017). From psychological moments to mortality: A multiscale view of cardiac vagal control, health, and disease. Neuroscience & Biobehavioral Reviews, 74(Pt B), 273–286.
• Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4565–4592.
• Ludwig, D. S., Willett, W. C., Volek, J. S., & Neuhouser, M. L. (2018). Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition, 44, 1–13.
• Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011). Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, (7), CD007506.
• Nestler, J. E. (1998). Metformin for the treatment of the polycystic ovary syndrome. The New England Journal of Medicine, 358(1), 47–54.
• Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. The New England Journal of Medicine, 342(19), 1378–1384.
• Rasmussen, K. M., & Yaktine, A. L. (Eds.). (2009). Weight Gain During Pregnancy: Reexamining the Guidelines. National Academies Press (US).
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction, 19(1), 41–47.
• Spiegel, K., Tasali, E., Penev, P., & Van Cauter, E. (2004). Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine, 141(11), 846–850.
• Suratt Trial Investigators, Malhotra, A., Grunstein, R. R., Fietze, I., Ayas, N., Gui, H., … & White, D. P. (2024). Tirzepatide for the treatment of obstructive sleep apnea and obesity. The New England Journal of Medicine, 390(25), 2351-2363.
• Taheri, S., Lin, L., Austin, D., Young, T., & Mignot, E. (2004). Short sleep duration is associated with lower leptin levels, higher ghrelin levels, and higher body mass index. PLoS Medicine, 1(3), e62.
• Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., … & Norman, R. J. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602–1618.
• Teede, H. J., Tay, C. T., Laven, J. J., Dokras, A., Moran, L. J., Piltonen, T. T., … & Norman, R. J. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. European Journal of Endocrinology, 189(2), G43–G64.
• Thayer, J. F., & Lane, R. D. (2009). Claude Bernard and the heart-brain connection: further elaboration of a model of neurovisceral integration. Neuroscience & Biobehavioral Reviews, 33(2), 81–88.
• Tilg, H., Moschen, A. R., & Roden, M. (2017). NAFLD and diabetes mellitus. Nature Reviews Gastroenterology & Hepatology, 14(1), 32–42.
• Walsh, B. T., Attia, E., Glasofer, D. R., Wang, Y., Wu, P., & Shu, A. (2022). Eating disorders in individuals with overweight and obesity. Current Psychiatry Reports, 24(11), 603–610.
• Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … & Wadden, T. A. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002.
• World Health Organization. (2023). Obesity and overweight.

 

SEO Tags: obesity care, PCOS treatment, insulin resistance, GLP-1 agonists, metformin PCOS, sleep apnea obesity, integrative chiropractic care, functional medicine obesity, El Paso clinic, Dr Alex Jimenez DC, Dr Maria Guadalupe Cardenas MD, reproductive health obesity, psychiatric considerations obesity, autonomic balance, lower carbohydrate nutrition, resistance training insulin sensitivity, pregnancy obesity risks, MASLD, endometrial protection, CBT-I sleep, multidisciplinary clinic Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Preconception Counseling, Maternal Obesity, Gestational Hypertension, Preeclampsia, Generational Health, Epigenetics, Breastfeeding Support, Tirzepatide, Semaglutide, Pregnancy Weight Gain, Postpartum Health, Metabolic Syndrome, Weight Management, Stress and Weight Gain, Eating Disorders, Binge Eating Disorder, Hormonal Imbalance, Bupropion Naltrexone, Phentermine, Mind-Body Connection, Chronic Inflammation, Basal Metabolic Rate, Case Study